Vaxxinova announces Director R&D and Director RA
Nijmegen, The Netherlands, Wednesday June 3, 2020.
Vaxxinova® Nederland BV is pleased to announce two new directors to its team as per June 1, 2020. Both positions are based in Nijmegen.
Mrs. Mirjam van der Sluijs will take up the role of Director R&D Nijmegen. As Director R&D Nijmegen Mirjam will lead the R&D and process development teams in Nijmegen and is responsible for the laboratories at this R&D site with the aim to bring innovative technologies and new products to the markets in Europe and the International Zone.
Mr. Rémon van Aubel has been appointed Director Regulatory Affairs Europe.
In this role Rémon will lead the Regulatory Affairs and Pharmacovigilance activities in Nijmegen, Netherlands, and Münster, Germany with the aim to register new products in Europe and the International Zone.